Veralox Therapeutics Private
Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type one diabetes. Based on an understanding of the molecular mechanisms of these diseases, these efforts will lead to new treatment paradigms and better outcomes for patients.
%20University%20System%20of%20Maryland.png)
%20Innovation%20Fund.png)
Industry:
PharmTech
Headquarters:
Frederick County, Virginia, United States
Employee Number:
1-10
Founded Date:
2017